Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020
In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39. Other driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
The major limiting factor of this market is the cost involved in the treatment. The patient may not conceive in the first cycle of IVF procedure. Many cycles have to be undergone by the patient to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $10,000-$20,000. This acts as a major limitation in adoption of the technique for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria. Awareness can be created through medical tourism and availability of low cost IVF treatments.
The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.
KEY BENEFITS
The major limiting factor of this market is the cost involved in the treatment. The patient may not conceive in the first cycle of IVF procedure. Many cycles have to be undergone by the patient to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $10,000-$20,000. This acts as a major limitation in adoption of the technique for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria. Awareness can be created through medical tourism and availability of low cost IVF treatments.
The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.
KEY BENEFITS
- In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographies
- Quantitative analysis of the current market and estimations through 2013-2020
- Assessment and ranking of the factors affecting the global market and impact analysis of the same
- Identification of key investment pockets in the market, which would assist companies to take profitable investment decisions
- Study of the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis
- Understanding the key intermediaries in the market based on value chain analysis
- Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
- SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions
- Hospitals
- Fertility clinics
- Instruments and reagent manufacturers
- Cryopreservation banks
- Government and private institutes
CHAPTER 1 INTRODUCTION
1.1 Key Benefits
1.2 Key Audiences
1.3 Research Methodology
1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 IUI technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.1.1 Egg sharing
3.5.2 Sperm donation
3.5.3 Embryo donation
3.5.4 Donation for research
3.6 Surrogacy
3.6.1 Legal issues
3.7 Rise in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced technologies in IVF
3.8.1 Capsule IVF
3.8.2 Three parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility treatment and Gender selection
3.9.1 Methods of sex selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Top ten factors impacting IVF market
3.14 Top winning strategies in the IVF market
3.15 Porter’s five forces analysis
3.15.1 Competition declining suppliers power
3.15.2 Availability of options impacting buyer power
3.15.3 High cost -a hindrance to new entrants
3.15.4 Application of strategies to overcome competition
3.15.5 Inefficient threat from substitutes
3.16 Value chain analysis
3.17 Insurance reimbursement Scenario
3.18 Regulatory issues and legislations
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20 Market dynamics
3.20.1 Drivers
3.20.1.1 Age
3.20.1.2 Rise in infertility rates
3.20.1.3 Advancement in technology
3.20.1.4 Rise in donation
3.20.1.5 Increase in average income
3.20.1.6 Increase in success rates
3.20.2 Restraints
3.20.2.1 Physical and emotional impact
3.20.2.2 Ethical and legal issues
3.20.2.3 Cost of the treatment
3.20.2.4 Multiple pregnancies
3.20.2.5 Low awareness level
3.20.3 Opportunities:
3.20.3.1 Medical tourism
3.20.3.2 New technology trends
3.20.3.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTS
4.1 Global IVF market by instruments types, 2012-2020,$million
4.2 Global IVF instruments market, by geography, 2012-2020, $million
4.3 Incubators
4.3.1 Global IVF incubators market , by geography, 2012-2020, $million
4.4 Cryosystem
4.4.1 Global IVF cryosystem market, by geography, 2012-2020, $million
4.5 Imaging system
4.5.1 Global IVF Imaging system market , by geography, 2012-2020, $million
4.6 Cabinet( work station)
4.6.1 Global IVF cabinets market , by geography, 2012-2020, $million
4.7 Ovum Aspiration pump
4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020, $million
4.8 Sperm separation system
4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020, $million
4.9 Accessories and disposables
4.9.1 Semen analysis chamber
4.9.2 Plastic ware
4.9.3 Oocyte retrieval needles
4.9.4 Miscellaneous disposables
4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020, $million
4.10 Micro Manipulator System
4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020, $million
4.11 Others
4.11.1 Refrigerators
4.11.1.1 Global IVF other instruments market , by geography, 2012-2020, $million
CHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIA
5.1 Global IVF market by reagents and media types,2012-2020,$million
5.2 Global IVF reagents and media market, by geography, 2012-2020, $million
5.3 Cryopreservation media
5.3.1 Embryo cryopreservation media
5.3.2 Sperm cryopreservation media
5.3.3 Oocyte cryopreservation media
5.3.3.1 Disadvantage
5.3.3.2 Advantages
5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020, $million
5.4 Semen processing media
5.4.1 Global IVF semen processing media market , by geography, 2012-2020, $million
5.5 Ovum processing media
5.5.1 Global IVF ovum processing media market , by geography, 2012-2020, $million
5.6 Embryo culture media
5.6.1 Global IVF embryo culture media market , by geography, 2012-2020, $million
CHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGY
6.1 Global IVF market, by technology, 2012-2020, $million
6.2 Global IVF technology market, by geography, 2012-2020, $million
6.3 PGD technique
6.3.1 Drivers
6.3.2 Restraints
6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020, $million
6.4 FER technique
6.4.1 Reasons to use this technique
6.4.2 Advantages of FER technique
6.4.3 Disadvantages of FER technique
6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020, $million
6.5 ICSI Technique
6.5.1 Benefits
6.5.2 Risks
6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020, $million
6.6 Others:
6.6.1 Global IVF other technology market , by geography, 2012-2020, $million
6.6.2 IVM Technique
6.6.3 Assisted hatching
CHAPTER 7 GLOBAL IVF MARKET BY END USERS
7.1 Global IVF market by end users, 2012-2020, $million
7.2 Global IVF end use market, by geography, 2012-2020, $million
7.3 Hospitals
7.3.1 Global IVF Hospitals market , by geography, 2012-2020, $million
7.4 Clinics
7.4.1 Global IVF Clinics market , by geography, 2012-2020, $million
7.5 Surgical centers
7.5.1 Global IVF Surgical centers market , by geography, 2012-2020, $million
7.6 Clinical research institutes
7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020, $million
7.7 Banks
7.7.1 Global IVF banks market , by geography, 2012-2020, $million
CHAPTER 8 IVF MARKET BY GEOGRAPHY
8.1 EMEA
8.2 North America
8.2.1 North American IVF market, 2012-2020, $million
8.3 Asia pacific
8.3.1 Asia Pacific IVF market, 2012-2020, $million
8.4 RoW
8.4.1 RoW IVF market, 2012-2020, $million
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Strategic moves and developments
9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreements
9.1.4.2 Others
9.1.5 SWOT Analysis of Vitrolife AB
9.2 EMD Serono, Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Strategic moves and developments
9.2.4.1 Primary strategies
9.2.5 SWOT Analysis of EMD Serono, Inc
9.3 Irvine scientific
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Strategic moves and developments
9.3.4.1 Primary strategy: FDA approvals
9.3.5 SWOT Analysis of Irvine scientific
9.4 Cooper Surgical, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Strategic moves and developments
9.4.4.1 Primary strategies
9.4.5 SWOT Analysis of Cooper Surgical, Inc
9.5 Cook Medical, Inc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Strategic moves and developments
9.5.3.1 Primary strategies
9.5.4 SWOT Analysis of Cook medical
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments
9.6.4.1 Primary strategy: product launch
9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments
9.7.3.1 Primary strategy: product launch
9.7.4 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Strategic moves and developments
9.8.3.1 Primary strategies- Agreement and partnership
9.8.3.2 Others strategies
9.8.4 SWOT Analysis of Auxogyn, Inc
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments
9.9.3.1 Primary strategy: product launch
9.9.4 SWOT analysis of oxford gene technology
9.10 Ovascience
9.10.1 Company overview
9.10.2 Business Performance
9.10.3 Strategic moves and developments
9.10.3.1 Primary strategy
9.10.4 SWOT analysis of Ovascience
1.1 Key Benefits
1.2 Key Audiences
1.3 Research Methodology
1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 IUI technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.1.1 Egg sharing
3.5.2 Sperm donation
3.5.3 Embryo donation
3.5.4 Donation for research
3.6 Surrogacy
3.6.1 Legal issues
3.7 Rise in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced technologies in IVF
3.8.1 Capsule IVF
3.8.2 Three parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility treatment and Gender selection
3.9.1 Methods of sex selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Top ten factors impacting IVF market
3.14 Top winning strategies in the IVF market
3.15 Porter’s five forces analysis
3.15.1 Competition declining suppliers power
3.15.2 Availability of options impacting buyer power
3.15.3 High cost -a hindrance to new entrants
3.15.4 Application of strategies to overcome competition
3.15.5 Inefficient threat from substitutes
3.16 Value chain analysis
3.17 Insurance reimbursement Scenario
3.18 Regulatory issues and legislations
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20 Market dynamics
3.20.1 Drivers
3.20.1.1 Age
3.20.1.2 Rise in infertility rates
3.20.1.3 Advancement in technology
3.20.1.4 Rise in donation
3.20.1.5 Increase in average income
3.20.1.6 Increase in success rates
3.20.2 Restraints
3.20.2.1 Physical and emotional impact
3.20.2.2 Ethical and legal issues
3.20.2.3 Cost of the treatment
3.20.2.4 Multiple pregnancies
3.20.2.5 Low awareness level
3.20.3 Opportunities:
3.20.3.1 Medical tourism
3.20.3.2 New technology trends
3.20.3.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTS
4.1 Global IVF market by instruments types, 2012-2020,$million
4.2 Global IVF instruments market, by geography, 2012-2020, $million
4.3 Incubators
4.3.1 Global IVF incubators market , by geography, 2012-2020, $million
4.4 Cryosystem
4.4.1 Global IVF cryosystem market, by geography, 2012-2020, $million
4.5 Imaging system
4.5.1 Global IVF Imaging system market , by geography, 2012-2020, $million
4.6 Cabinet( work station)
4.6.1 Global IVF cabinets market , by geography, 2012-2020, $million
4.7 Ovum Aspiration pump
4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020, $million
4.8 Sperm separation system
4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020, $million
4.9 Accessories and disposables
4.9.1 Semen analysis chamber
4.9.2 Plastic ware
4.9.3 Oocyte retrieval needles
4.9.4 Miscellaneous disposables
4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020, $million
4.10 Micro Manipulator System
4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020, $million
4.11 Others
4.11.1 Refrigerators
4.11.1.1 Global IVF other instruments market , by geography, 2012-2020, $million
CHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIA
5.1 Global IVF market by reagents and media types,2012-2020,$million
5.2 Global IVF reagents and media market, by geography, 2012-2020, $million
5.3 Cryopreservation media
5.3.1 Embryo cryopreservation media
5.3.2 Sperm cryopreservation media
5.3.3 Oocyte cryopreservation media
5.3.3.1 Disadvantage
5.3.3.2 Advantages
5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020, $million
5.4 Semen processing media
5.4.1 Global IVF semen processing media market , by geography, 2012-2020, $million
5.5 Ovum processing media
5.5.1 Global IVF ovum processing media market , by geography, 2012-2020, $million
5.6 Embryo culture media
5.6.1 Global IVF embryo culture media market , by geography, 2012-2020, $million
CHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGY
6.1 Global IVF market, by technology, 2012-2020, $million
6.2 Global IVF technology market, by geography, 2012-2020, $million
6.3 PGD technique
6.3.1 Drivers
6.3.2 Restraints
6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020, $million
6.4 FER technique
6.4.1 Reasons to use this technique
6.4.2 Advantages of FER technique
6.4.3 Disadvantages of FER technique
6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020, $million
6.5 ICSI Technique
6.5.1 Benefits
6.5.2 Risks
6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020, $million
6.6 Others:
6.6.1 Global IVF other technology market , by geography, 2012-2020, $million
6.6.2 IVM Technique
6.6.3 Assisted hatching
CHAPTER 7 GLOBAL IVF MARKET BY END USERS
7.1 Global IVF market by end users, 2012-2020, $million
7.2 Global IVF end use market, by geography, 2012-2020, $million
7.3 Hospitals
7.3.1 Global IVF Hospitals market , by geography, 2012-2020, $million
7.4 Clinics
7.4.1 Global IVF Clinics market , by geography, 2012-2020, $million
7.5 Surgical centers
7.5.1 Global IVF Surgical centers market , by geography, 2012-2020, $million
7.6 Clinical research institutes
7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020, $million
7.7 Banks
7.7.1 Global IVF banks market , by geography, 2012-2020, $million
CHAPTER 8 IVF MARKET BY GEOGRAPHY
8.1 EMEA
8.2 North America
8.2.1 North American IVF market, 2012-2020, $million
8.3 Asia pacific
8.3.1 Asia Pacific IVF market, 2012-2020, $million
8.4 RoW
8.4.1 RoW IVF market, 2012-2020, $million
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Strategic moves and developments
9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreements
9.1.4.2 Others
9.1.5 SWOT Analysis of Vitrolife AB
9.2 EMD Serono, Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Strategic moves and developments
9.2.4.1 Primary strategies
9.2.5 SWOT Analysis of EMD Serono, Inc
9.3 Irvine scientific
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Strategic moves and developments
9.3.4.1 Primary strategy: FDA approvals
9.3.5 SWOT Analysis of Irvine scientific
9.4 Cooper Surgical, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Strategic moves and developments
9.4.4.1 Primary strategies
9.4.5 SWOT Analysis of Cooper Surgical, Inc
9.5 Cook Medical, Inc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Strategic moves and developments
9.5.3.1 Primary strategies
9.5.4 SWOT Analysis of Cook medical
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments
9.6.4.1 Primary strategy: product launch
9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments
9.7.3.1 Primary strategy: product launch
9.7.4 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Strategic moves and developments
9.8.3.1 Primary strategies- Agreement and partnership
9.8.3.2 Others strategies
9.8.4 SWOT Analysis of Auxogyn, Inc
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments
9.9.3.1 Primary strategy: product launch
9.9.4 SWOT analysis of oxford gene technology
9.10 Ovascience
9.10.1 Company overview
9.10.2 Business Performance
9.10.3 Strategic moves and developments
9.10.3.1 Primary strategy
9.10.4 SWOT analysis of Ovascience
LIST OF TABLES
TABLE 1 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 2 INSURANCE COVERAGE FOR COUNTRIES
TABLE 3 GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020,$MILLION
TABLE 4 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 5 GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6 GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 7 GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 8 GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9 GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 10 GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 11 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 12 GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 13 GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 14 GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLION
TABLE 15 GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 16 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 17 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 19 GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 22 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 23 GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 24 GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25 GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26 GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27 GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28 GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 29 GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLION
TABLE 30 GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31 GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32 GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33 GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 34 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35 GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36 EUROPE’S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010
TABLE 37 EMEA IVF MARKET, 2012-2020, $MILLION
TABLE 38 NORTH AMERICAN IVF MARKET, 2012-2020, $MILLION
TABLE 39 ASIA PACIFIC IVF MARKET, 2012-2020, $MILLION
TABLE 40 ROW IVF MARKET, 2012-2020, $MILLION
TABLE 41 SNAP SHOT OF VITROLIFE AB
TABLE 42 SNAP SHOT OF EMD SERONO, INC
TABLE 43 SNAP SHOT OF IRVINE SCIENTIFIC
TABLE 44 SNAP SHOT OF COOPER SURGICAL, INC
TABLE 45 SNAP SHOT OF COOK MEDICAL
TABLE 46 SNAP SHOT OF THERMO FISHER SCIENTIFIC INC
TABLE 47 SNAP SHOT OF GENEA BIOMEDX
TABLE 48 SNAP SHOT OF AUXOGYN, INC
TABLE 49 SNAP SHOT OF OXFORD GENE TECHNOLOGY
TABLE 50 SNAP SHOT OF OVASCIENCE
TABLE 1 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 2 INSURANCE COVERAGE FOR COUNTRIES
TABLE 3 GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020,$MILLION
TABLE 4 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 5 GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6 GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 7 GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 8 GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9 GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 10 GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 11 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 12 GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 13 GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 14 GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLION
TABLE 15 GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 16 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 17 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 19 GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 22 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 23 GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 24 GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25 GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26 GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27 GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28 GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 29 GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLION
TABLE 30 GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31 GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32 GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33 GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 34 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35 GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36 EUROPE’S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010
TABLE 37 EMEA IVF MARKET, 2012-2020, $MILLION
TABLE 38 NORTH AMERICAN IVF MARKET, 2012-2020, $MILLION
TABLE 39 ASIA PACIFIC IVF MARKET, 2012-2020, $MILLION
TABLE 40 ROW IVF MARKET, 2012-2020, $MILLION
TABLE 41 SNAP SHOT OF VITROLIFE AB
TABLE 42 SNAP SHOT OF EMD SERONO, INC
TABLE 43 SNAP SHOT OF IRVINE SCIENTIFIC
TABLE 44 SNAP SHOT OF COOPER SURGICAL, INC
TABLE 45 SNAP SHOT OF COOK MEDICAL
TABLE 46 SNAP SHOT OF THERMO FISHER SCIENTIFIC INC
TABLE 47 SNAP SHOT OF GENEA BIOMEDX
TABLE 48 SNAP SHOT OF AUXOGYN, INC
TABLE 49 SNAP SHOT OF OXFORD GENE TECHNOLOGY
TABLE 50 SNAP SHOT OF OVASCIENCE
LIST OF FIGURES
FIG. 1 IUI SUCCESS RATES BY AGE UK, 2010
FIG. 2 HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUE
FIG. 3 COST OF BASIC IVF TYPE PROCEDURES
FIG. 4 PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011
FIG. 5 LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010
FIG. 6 EMBRYOS CREATED USING DONOR EGGS, EUROPE
FIG. 7 ADOPTION RATE BY TYPE OF SURROGACY
FIG. 8 TOP FACTORS IMPACTING IVF MARKET (2013-2020)
FIG. 9 TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)
FIG. 10 PORTER’S FIVE FORCE ANALYSIS:
FIG. 11 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12 EFFECT OF AGE ON FERTILITY
FIG. 13 COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 14 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.A
FIG. 15 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)
FIG. 16 LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)
FIG. 17 PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011
FIG. 18 PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.K
FIG. 19 POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
FIG. 20 SALES PER REGION 2012
FIG. 21 SWOT ANALYSIS OF VITROLIFE AB
FIG. 22 SALES BY REGION, 2012
FIG. 23 SWOT ANALYSIS OF EMD SERONO, INC
FIG. 24 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25 SWOT ANALYSIS OF COOPER SURGICAL, INC
FIG. 26 SWOT ANALYSIS OF COOK MEDICAL
FIG. 27 FINANCIAL REVENUES BY BUSINESS UNITS (2012)
FIG. 28 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 29 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.
FIG. 30 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31 SWOT ANALYSIS OF AUXOGYN, INC
FIG. 32 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 33 SWOT ANALYSIS OF OVASCIENCE
COMPANIES MENTIONED
Vitrolife AB, EMD Serono, Inc, Irvine scientific, Cooper Surgical, Inc., Cook Medical, Inc, Thermo Fisher Scientific Inc., Genea Biomedx, Auxogyn, Inc, Oxford Gene Technology and Ovascience
FIG. 1 IUI SUCCESS RATES BY AGE UK, 2010
FIG. 2 HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUE
FIG. 3 COST OF BASIC IVF TYPE PROCEDURES
FIG. 4 PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011
FIG. 5 LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010
FIG. 6 EMBRYOS CREATED USING DONOR EGGS, EUROPE
FIG. 7 ADOPTION RATE BY TYPE OF SURROGACY
FIG. 8 TOP FACTORS IMPACTING IVF MARKET (2013-2020)
FIG. 9 TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)
FIG. 10 PORTER’S FIVE FORCE ANALYSIS:
FIG. 11 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12 EFFECT OF AGE ON FERTILITY
FIG. 13 COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 14 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.A
FIG. 15 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)
FIG. 16 LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)
FIG. 17 PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011
FIG. 18 PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.K
FIG. 19 POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
FIG. 20 SALES PER REGION 2012
FIG. 21 SWOT ANALYSIS OF VITROLIFE AB
FIG. 22 SALES BY REGION, 2012
FIG. 23 SWOT ANALYSIS OF EMD SERONO, INC
FIG. 24 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25 SWOT ANALYSIS OF COOPER SURGICAL, INC
FIG. 26 SWOT ANALYSIS OF COOK MEDICAL
FIG. 27 FINANCIAL REVENUES BY BUSINESS UNITS (2012)
FIG. 28 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 29 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.
FIG. 30 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31 SWOT ANALYSIS OF AUXOGYN, INC
FIG. 32 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 33 SWOT ANALYSIS OF OVASCIENCE
COMPANIES MENTIONED
Vitrolife AB, EMD Serono, Inc, Irvine scientific, Cooper Surgical, Inc., Cook Medical, Inc, Thermo Fisher Scientific Inc., Genea Biomedx, Auxogyn, Inc, Oxford Gene Technology and Ovascience
